Share-based Payment Arrangement, Expense in USD of Medicus Pharma Ltd. from 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Medicus Pharma Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2023 to Q3 2025.
  • Medicus Pharma Ltd. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $853K.
  • Medicus Pharma Ltd. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $1.17M.
  • Medicus Pharma Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $713K, a 623% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Medicus Pharma Ltd. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.17M $853K +$853K Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $321K $117K -$468K -79.9% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $789K $112K +$76.3K +212% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $713K $91.7K Oct 1, 2024 Dec 31, 2024 10-K 2025-03-28
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $585K Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $36K Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12

Medicus Pharma Ltd. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $713K +$615K +623% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-28
2023 $98.6K Jan 1, 2023 Dec 31, 2023 10-K 2025-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.